Quality of life and satisfaction among prostate cancer patients followed in a dedicated survivorship clinic - Abstract

BACKGROUND: Integrating quality-of-life (QOL) outcomes into clinics may assist providers in identifying and responding to problems experienced by cancer survivors.

To date, however, patient-reported outcomes (PROs) such as QOL are used infrequently to guide care. We integrated QOL assessments into a prostate cancer survivorship clinic and compared recovery and satisfaction among men managed in the survivorship clinic with those followed with more routine care.

METHODS: We conducted a before-after study comparing 235 men treated surgically for prostate cancer who received routine follow-up care with 102 men managed in a survivorship clinic characterized by point-of-care QOL reporting and integration of QOL scores (EPIC) following radical prostatectomy. We then assessed baseline and post prostatectomy QOL at 6 and 12 months, as well as patient satisfaction, and compared outcomes between groups.

RESULTS: Although baseline QOL was comparable, scores were generally higher among the survivorship group at 6 months and 1 year compared with those followed with routine care. In particular, sexual function scores were significantly higher among patients managed in the survivorship clinic (52.2 vs 33.6 at 1 year, P < .01). Satisfaction scores were consistently higher in the survivorship clinic group compared with the routine-care group (all P < .05).

CONCLUSIONS: Patient QOL and satisfaction were higher among men managed in a survivorship program, suggesting that disease-specific survivorship clinics that integrate QOL reporting into care pathways may yield better outcomes compared with less tailored approaches to patient care following cancer therapy.

Written by:
Gilbert SM, Dunn RL, Wittmann D, Montgomery JS, Hollingsworth JM, Miller DC, Hollenbeck BK, Wei JT, Montie JE.   Are you the author?
Genitourinary Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; Health Outcomes and Behavior Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

Reference: Cancer. 2014 Dec 23. Epub ahead of print.
doi: 10.1002/cncr.29215

PubMed Abstract
PMID: 25538017

UroToday.com Prostate Cancer Section